Intelligent Design: Combination Therapy With Oncolytic Viruses

This publication has 151 references indexed in Scilit:

• Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy
  Molecular Therapy, 2009
• Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells
  Cancer Gene Therapy, 2009
• Phase I Study of Noninvasive Imaging of Adenovirus-mediated Gene Expression in the Human Prostate
  Molecular Therapy, 2008
• JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase
  Cancer Gene Therapy, 2008
• Efficacy and Safety of the Oncolytic Herpes Simplex Virus rRp450 Alone and Combined With Cyclophosphamide
  Molecular Therapy, 2008
• Heat shock protein inhibitors increase the efficacy of measles virotherapy
  Gene Therapy, 2008
• E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models
  Cancer Gene Therapy, 2007
• Cyclophosphamide Increases Transgene Expression Mediated by an Oncolytic Adenovirus in Glioma-Bearing Mice Monitored by Bioluminescence Imaging
  Molecular Therapy, 2006
• Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin
  British Journal of Cancer, 2006
• Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
  Nature Reviews Cancer, 2006